Philip John Brooks (P J Brooks)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Ejection Fraction

Finite Element Analysis

Top Venues

American journal of medical genetics. Part C, Seminars in medical genetics

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Philip John Brooks, Tiina K Urv, Melissa A Parisi
Gene-targeted therapies: Overview and implications. American journal of medical genetics. Part C, Seminars in medical genetics 193 (1) (2023)
Philip John Brooks, Tiina K Urv, Melissa A Parisi
Gene-targeted therapies: Overview and implications. American journal of medical genetics. Part C, Seminars in medical genetics (2023)
Julie Lekstrom-Himes, Philip John Brooks, Dwight D Koeberl, Amy M Brower, Aaron J Goldenberg, Robert C Green, Jill A Morris, Joseph J Orsini, Timothy W Yu, Erika F Augustine
Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies. American journal of medical genetics. Part C, Seminars in medical genetics (2023)
Julie Lekstrom-Himes, Philip John Brooks, Dwight D Koeberl, Amy M Brower, Aaron J Goldenberg, Robert C Green, Jill A Morris, Joseph J Orsini, Timothy W Yu, Erika F Augustine
Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies. American journal of medical genetics. Part C, Seminars in medical genetics (2023)
Galliano Zanello, Macarena Garrido-Estepa, Ana Crespo, Daniel O'Connor, Rima Nabbout, Christina Waters, Anthony Hall, Taglialatela Maurizio, Chun-Hung Chan, David A Pearce, Marc Dooms, Philip John Brooks
Targeting shared molecular etiologies to accelerate drug development for rare diseases. EMBO molecular medicine (2023)
Julie Lekstrom-Himes, Philip John Brooks, Dwight D Koeberl, Amy M Brower, Aaron J Goldenberg, Robert C Green, Jill A Morris, Joseph J Orsini, Timothy W Yu, Erika F Augustine
Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies. American journal of medical genetics. Part C, Seminars in medical genetics 193 (1) (2023)